Tuesday, 31 July 2018

Global Prefilled Syringes Market – Analysis and Forecast (2018-2024)


Prefilled syringe is a single use syringe filled with parenteral drug. It helps to exclude various numbers of procedures mandatory for administering a formulation. The global prefilled syringes market is growing at significant rate, due to mounting demand for biologics and biosimilars and emergent injectable drugs pipeline. Different types of syringes contributed to the market size. The market has witnessed high demand for conventional syringes over the last few years due to increasing adoption of self-administered injectable drug.


There are two materials of syringes, glass and plastic. Glass material is preferred for manufacturing syringe as the material is non-reactive, and have high mechanical strength, and tolerability towards heat and transparency. However, the raised leachability from silicon layer in the presence of biologics is also transferring the usage of glass to plastic. Of both, plastic prefilled syringes market witnessed the higher growth worldwide, which is due to break resistance and decreased surface reactivity.

Moreover, increasing demand for vaccine, large pool of population base and benefits associated with syringes are also up surging its demand, as parentral administration is second most common mode of drug delivery. According to the World Health Organization (WHO), globally approximately 16 billion injections are administered every year in developing and transitional countries.

Drug is delivered with various methods, such as orally, infusion, and injections. Oral delivery method is the most commonly used drug delivery alternative globally, as it is cost effective and easy to use for patients. Interaction of syringe plastic with the drugs and recall of products are the key factor hindering the global market growth.


Geographically, Europe is the largest prefilled syringe market as in the region the prevalence of chronic disease is increasing. The increasing prevalence of diabetes is a major concern in Europe. According to International Diabetes Federation (IDF) in 2015, approximately 59.8 million people were suffering from diabetes in Europe. In addition, the healthcare expenditure is increasing in Europe, which has increased the accessibility and affordability of treatment among the individuals. Growing geriatric population, increasing demand for biosimilars and biologics and technological advancement of products are also up surging growth of the European prefilled syringes market.

Key players in the prefilled syringes industry are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. According to Unilife Corporation, a company involved in the development, design and production of injectable drug delivery system, approximately 2 billion prefilled syringes are used each year globally. Becton, Dickinson and Company, Weigao Group, Gerresheimer AG, SCHOTT AG, Catalent, Inc., West Pharmaceutical Services, Inc., Ompi, Vetter Pharma International GmbH, Nipro Corporation, and MedPro Inc. are the key players offering prefilled syringes.

Contact

VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook




No comments:

Post a Comment